Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Zapata-Cobo P, Salvador-Matín S, Velasco M, Palomino LM, Clemente S, Segarra O, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Montraveta M, Sánchez C, Tolín M, Loverdos I, Fobelo MJ, Navas-López VM, Magallares L, García-Romero R, Sánchez-Hernández JG, Rodríguez A, Bossacoma F, Balboa MJ, Salcedo E, Sanjurjo-Sáez M, López-Fernández LA. Zapata-Cobo P, et al. Among authors: navas lopez vm. Pharmacol Res. 2023 Oct;196:106938. doi: 10.1016/j.phrs.2023.106938. Epub 2023 Sep 23. Pharmacol Res. 2023. PMID: 37748560 Free article. No abstract available.
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.
Salvador-Martín S, Rubbini G, Vellosillo P, Zapata-Cobo P, Velasco M, Palomino LM, Clemente S, Segarra O, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Montraveta M, Sánchez C, Tolín M, Loverdos I, Fobelo MJ, Navas-López VM, Magallares L, García-Romero R, Torres-Peral R, Rodríguez A, Bossacoma F, Merino-Bohórquez V, Salcedo E, Álvarez R, Dopazo A, Sanjurjo-Sáez M, López-Fernández LA. Salvador-Martín S, et al. Among authors: navas lopez vm. Biomed Pharmacother. 2024 Apr;173:116299. doi: 10.1016/j.biopha.2024.116299. Epub 2024 Feb 23. Biomed Pharmacother. 2024. PMID: 38401525 Free article.
Assessment of the length of sick leave in patients with inflammatory bowel disease.
Ramos Cózar SN, Masot RM, Gallego BR, Rubio L, Cabanillas Moruno JL, Navas López VM. Ramos Cózar SN, et al. Among authors: navas lopez vm. Gastroenterol Hepatol. 2024 May 5:502194. doi: 10.1016/j.gastrohep.2024.502194. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38714272 English, Spanish.
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN.
Cohen S, Rolandsdotter H, Kolho KL, Turner D, Tzivinikos C, Bramuzzo M, Pujol-Muncunill G, Scarallo L, Urlep D, Rinawi F, Granot M, Kang B, Longueville Y, Rodríguez-Belvís MV, Weintraub Y, Navas-López VM, Yerushalmy-Feler A. Cohen S, et al. Among authors: navas lopez vm. Paediatr Drugs. 2024 May 23. doi: 10.1007/s40272-024-00631-z. Online ahead of print. Paediatr Drugs. 2024. PMID: 38780740
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP.
Velasco Rodríguez-Belvís M, Palomino L, Pujol-Muncunill G, Martin-Masot R, Medina Benítez E, Fernández-Lorenzo AE, Moreno-Álvarez A, Molina Arias M, Hidalgo Montes I, Barrio Torres J, Navas-López VM, Martín de Carpi J, Lozano Ruf A, Blasco-Alonso J, Barrio Torres J, Montraveta M, Peña-Quintana L, Ramos Rueda N, Rodríguez Martínez A, Botija Arcos G, Alonso Vicente C, Castro Millán AM, Donat E, Fernández Cebrián S, Sánchez Sánchez C, Loverdos I, Segarra Cantón O, Ruiz Castellano N, Torres-Peral R, Crehuá-Gaudiza E, Millán Jiménez A, Jovani Casano C, Vicente Santamaría S, Tabares González A, Garcia-Romero R, Ros Arnal I, Balboa Vega MJ, Escartín Madurga L, Martinón Torres N, Crujeiras Martínez V, González-Vives L, Pérez-Moneo B, Masiques Mas ML, Vegas Álvarez AM, Grande Herrero L, La Orden Izquierdo E, Chicano Marín FJ, de Las Mercedes Busto Cuiñas M, Martínez de Zabarte Fernández JM, Alberto Alonso JR, Andrés Esteban EM. Velasco Rodríguez-Belvís M, et al. Among authors: navas lopez vm. Eur J Pediatr. 2024 May 21. doi: 10.1007/s00431-024-05575-7. Online ahead of print. Eur J Pediatr. 2024. PMID: 38771373
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN.
Pujol-Muncunill G, Navas-López VM, Ledder O, Cohen S, Lekar M, Turner D, Kolho KL, Levine A, Croft NM, Bronsky J, Shouval DS, Assa A, Harris R, Kiparissi F, Aloi M, Afzal NA, Tzivinikos C, Barrio J, Norden C, Vega MJB, Buderus S, de Valderrama AF, de Ridder L, García-Romero R, Medina E, Sánchez C, Velasco M, Vicente S, Wilson DC, Naik S, Hradsky O, Cococcioni L, Martin-de-Carpi J. Pujol-Muncunill G, et al. Among authors: navas lopez vm. Eur J Pediatr. 2024 May 3. doi: 10.1007/s00431-024-05588-2. Online ahead of print. Eur J Pediatr. 2024. PMID: 38700692
Mitochondrial Stress Links Environmental Triggers with Pro-Inflammatory Signaling in Crohn's Disease.
Martín-Reyes F, Bernal M, Rodríguez-Díaz C, Rodríguez-de Los Reyes D, Ho-Plagaro A, Rodríguez-Pacheco F, Camacho-Martel L, Camargo-Camero R, Rodríguez-González FJ, Alcain-Martínez G, Martín-Masot R, Navas-López VM, Villanueva-Paz M, Lucena MI, García-Fuentes E, López-Gómez C. Martín-Reyes F, et al. Among authors: navas lopez vm. Antioxidants (Basel). 2023 Dec 13;12(12):2105. doi: 10.3390/antiox12122105. Antioxidants (Basel). 2023. PMID: 38136224 Free PMC article.
113 results